These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30537813)
1. Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His Jia L; Wang W; Sang J; Wei W; Zhao W; Lu F; Liu F ACS Chem Neurosci; 2019 Mar; 10(3):1251-1262. PubMed ID: 30537813 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a highly soluble Aβ LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755 [TBL] [Abstract][Full Text] [Related]
3. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure. Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556 [TBL] [Abstract][Full Text] [Related]
4. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro. Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038 [TBL] [Abstract][Full Text] [Related]
5. Nitration of Tyrosine Residue Y10 of Aβ Zhao J; Wu J; Yang Z; Li H; Gao Z Chem Res Toxicol; 2017 Apr; 30(4):1085-1092. PubMed ID: 28272880 [TBL] [Abstract][Full Text] [Related]
6. Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer's agent. Hu S; Xian Y; Fan Y; Mak S; Wang J; Tang J; Pang Y; Pi R; Tsim KW; Liu F; Lin Z; Han Y Eur J Pharmacol; 2020 Jun; 876():173065. PubMed ID: 32171792 [TBL] [Abstract][Full Text] [Related]
7. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ Hojati S; Ghahghaei A; Lagzian M J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568 [TBL] [Abstract][Full Text] [Related]
9. The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity. Foroutanpay BV; Kumar J; Kang SG; Danaei N; Westaway D; Sim VL; Kar S Neuroscience; 2018 May; 379():177-188. PubMed ID: 29572166 [TBL] [Abstract][Full Text] [Related]
10. Virtual and In Vitro Screens Reveal a Potential Pharmacophore that Avoids the Fibrillization of Aβ1-42. Hernández-Rodríguez M; Correa-Basurto J; Nicolás-Vázquez MI; Miranda-Ruvalcaba R; Benítez-Cardoza CG; Reséndiz-Albor AA; Méndez-Méndez JV; Rosales-Hernández MC PLoS One; 2015; 10(7):e0130263. PubMed ID: 26172152 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Aβ (1-40, 1-28, 11-22, and 29-40) aggregation processes and inhibition of toxic species generated in early stages of aggregation by a water-soluble ruthenium complex. Cali MP; Pereira LMB; Teodoro MD; Sellani TA; Rodrigues EG; Carlos RM J Inorg Biochem; 2021 Feb; 215():111314. PubMed ID: 33261934 [TBL] [Abstract][Full Text] [Related]
12. Location and conformation of amyloid β(25-35) peptide and its sequence-shuffled peptides within membranes: implications for aggregation and toxicity in PC12 cells. Tsai HH; Lee JB; Shih YC; Wan L; Shieh FK; Chen CY ChemMedChem; 2014 May; 9(5):1002-11. PubMed ID: 24729535 [TBL] [Abstract][Full Text] [Related]
13. Direct evidence for self-propagation of different amyloid-β fibril conformations. Spirig T; Ovchinnikova O; Vagt T; Glockshuber R Neurodegener Dis; 2014; 14(3):151-9. PubMed ID: 25300967 [TBL] [Abstract][Full Text] [Related]
14. Aβ41 Aggregates More Like Aβ40 than Like Aβ42: In Silico and in Vitro Study. Nguyen HL; Thi Minh Thu T; Truong PM; Lan PD; Man VH; Nguyen PH; Tu LA; Chen YC; Li MS J Phys Chem B; 2016 Aug; 120(30):7371-9. PubMed ID: 27388669 [TBL] [Abstract][Full Text] [Related]
15. Aβ Anand BG; Prajapati KP; Kar K Biochem Biophys Res Commun; 2018 Jun; 501(1):158-164. PubMed ID: 29723530 [TBL] [Abstract][Full Text] [Related]
16. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Sun Y; Qian Z; Wei G Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578 [TBL] [Abstract][Full Text] [Related]
17. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro. Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction. Colombo L; Gamba A; Cantù L; Salmona M; Tagliavini F; Rondelli V; Del Favero E; Brocca P Biophys Chem; 2017 Oct; 229():11-18. PubMed ID: 28502484 [TBL] [Abstract][Full Text] [Related]
19. Binding of Cu Taniguchi M; Saito M; Kuga T; Yamagishi N Biochem Biophys Res Commun; 2021 Jan; 534():617-623. PubMed ID: 33208229 [TBL] [Abstract][Full Text] [Related]
20. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties. Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]